No Data
12 Health Care Stocks Moving In Monday's After-Market Session
Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics (KPTI) Looks Ripe for a Turnaround
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm to Participate at Upcoming Investor Conferences
Michael Mason Resigns as CFO of Karyopharm Therapeutics
Express News | Karyopharm Therapeutics Inc - Initiated a Search for a Successor